Trimethoprim-polymyxin B ophthalmic solution in treatment of surface ocular bacterial infections.
A safety and efficacy study comparing the clinical and bacteriologic effectiveness of trimethoprim-sulfacetamide-polymyxin B-neomycin-gramicidin in a group of patients with surface ocular bacterial infections was conducted. The results demonstrated TSP to be as effective as the other solution (both clinically and bacteriologically), with fewer adverse experiences. A second study was conducted comparing TSP with trimethoprim-polymyxin B (TP) and found TP to be superior to TSP in effecting bacteriologic cures. Clinical response was similar in both groups, and the low incidence of mild adverse experiences was approximately the same. It appears that the combination of trimethoprim with polymyxin B is safe and highly efficacious, both clinically and microbiologically, for the treatment of surface ocular bacterial infections.
R A
RA
Nozik
G
G
Smolin
G
G
Knowlton
R
R
Austin
D000293:Adolescent; D000328:Adult; D000368:Aged; D001424:Bacterial Infections / Q000188:drug therapy*; D001762:Blepharitis / Q000188:drug therapy*; D002648:Child; D003234:Conjunctivitis, Bacterial / Q000188:drug therapy*; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D005141:Eyelid Diseases / Q000188:drug therapy*; D005260:Female; D006096:Gramicidin / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009355:Neomycin / Q000627:therapeutic use; D009883:Ophthalmic Solutions; D011112:Polymyxin B / Q000627:therapeutic use*; D011113:Polymyxins / Q000627:therapeutic use*; D013409:Sulfacetamide / Q000627:therapeutic use*; D014295:Trimethoprim / Q000627:therapeutic use*
D009883:Ophthalmic Solutions; D011113:Polymyxins; D006096:Gramicidin; D013409:Sulfacetamide; D014295:Trimethoprim; D009355:Neomycin; D011112:Polymyxin B